New Rosacea Treatments

One of the hottest areas of interest online for rosacea sufferers is new rosacea treatments. From the industry heavyweights like Galderma, Allergan, Bayer, Valeant and Stiefel to little companies like MooGoo there is a lot of interest in the up and coming rosacea treatments. See below for the latest information about what is just over the horizon.

Recent Rosacea Blog Posts

Cliradex T4O wipes for treating Eye Lash Mites

In mid 2012 we learned that a company called Tissue Tech was going to trial single use T4O wipes as a treatment for ocular demodex mites. Early last year Bio-Tissue Inc., the parent company of Tissue Tech announced the release of Cliradex. This new product is promoted as a tea tree oil based moist towelette […]

Continue Reading

Nasalcrom regulates Mast Cells – reduces redness

In September last year a trial was listed to assess whether cromolyn sodium ophthalmic solution 4% could improve the redness associated with rosacea. This trial was listed by Dr. Anna Di Nardo, who is a part of the UCSD and has received NRS funding in 2012 to research the link between Mast Cells and the […]

Continue Reading

Linda Stein Gold mentions in a video posted on Skin and Allergy News, referring to Galderma’s Ivermectin Cream ; Phase 3 Clinical Trials have completed, and FDA Approval is expected later this year (2014). This is great new for those who 1) want to try an approved treatment for demodex mites and 2) may not […]

Continue Reading

Afrin (Oxymetazoline) Safe Off Label Drug for a Red Face

This paper from Hospital Pharmacy is giving a guarded approval for the use of Oxymetazoline topically for the redness of rosacea. Even though the FDA has not approved Oxymetazoline as a topical skin treatment, it is approved as a nasal decongestant. Doctors are able to prescribe drugs for off-label use, that is once a drug […]

Continue Reading

Mirvaso European Availability by March 2014

A Medscape article today announces that Mirvaso has been granted human approval and should be approved for sale across Europe by March 2014. The initial authorisation to market Mirvaso has been granted and are normally issued 67 days from the adoption of the `Summary of opinion’ Mirvaso Gains CHMP Support for Rosacea Erythema Treatment Miriam […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.